Bonus BioGroup Ltd.
TLV: BONS.TA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tel Aviv Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Shai Meretzki
- Employees
- 49
- Headquarters
- Haifa, Israel
- IPO year
- 2002
- Market cap
- ILA 471.8M
- Website
- https://bonus-bio.com
Loading BONS…
Loading profile data…Frequently asked questions about BONS
What does Bonus BioGroup Ltd. (BONS.TA) do?
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products include BonoFill for bone tissue regeneration in maxillofacial and orthopedic indications; and MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS, as well as other life-t...
Where does BONS.TA trade?
Bonus BioGroup Ltd. (BONS.TA) trades on the Tel Aviv Stock Exchange.
What sector is BONS.TA in?
Bonus BioGroup Ltd. (BONS.TA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Bonus BioGroup Ltd.?
Shai Meretzki is the chief executive officer of Bonus BioGroup Ltd. (BONS.TA).
Where is Bonus BioGroup Ltd. headquartered?
Bonus BioGroup Ltd. is headquartered in Israel.
Does BONS.TA pay a dividend?
Bonus BioGroup Ltd. (BONS.TA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BONS.TA go public?
Bonus BioGroup Ltd. (BONS.TA) completed its initial public offering in 2002.